Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COM PAR
-
Total 13F shares
-
1,058,252
-
Share change
-
+1,242
-
Total reported value
-
$5,319,359
-
Price per share
-
$5.00
-
Number of holders
-
31
-
Value change
-
+$5,375
-
Number of buys
-
12
-
Number of sells
-
9
Institutional Holders of IMMUCELL CORP /DE/ - COM PAR (ICCC) as of Q2 2023
As of 30 Jun 2023,
IMMUCELL CORP /DE/ - COM PAR (ICCC) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,058,252 shares.
The largest 10 holders included
VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Bleichroeder LP, Cresset Asset Management, LLC, MORGAN STANLEY, DIMENSIONAL FUND ADVISORS LP, SHUFRO ROSE & CO LLC, GEODE CAPITAL MANAGEMENT, LLC, Empire Financial Management Company, LLC, and OVERBROOK MANAGEMENT CORP.
This page lists
31
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.